Home
On-Demand
Industrie
FAQ
Login MyUpdate
Home
On-Demand
Industrie
FAQ
Login MyUpdate
Schlagwort
RCTX
Tumore unterer GI-Trakt
Tumore unterer GI-Trakt
Analkarzinom
/
ARO-12
/
CAO-ARO-AIO-12
/
dMMR
/
FFCD 0904-Studie
/
Kontakt-Brachytherapie
/
OPRA-Studie
/
Panitumumab
/
PD-1-Blockade
/
PRODIGE-23
/
QLQ-CR29
/
QoL/Toxizität
/
RAPIDO
/
RCTX
/
Rektumkarzinom
/
UNICANCER-ACCORD-16
Genitalkarzinome
Genitalkarzinome
Adenokarzinom
/
ALTALANTE-Studie
/
bevacizumab
/
BRCAm
/
CALLA-Studie
/
Cemiplimab
/
Cisplatin
/
Durvalumab
/
innovaTV 204-Studie
/
Lenvatinib
/
Paclitaxel
/
Pembrolizumab
/
RCTX
/
Tisotumab-Vedotin
/
Trastuzumab
Kopf-Hals-Tumore
Kopf-Hals-Tumore
Avelumab
/
Carboplatin
/
Cetuximab
/
Cisplatin
/
Doxetaxel
/
E3311
/
ECOG-ACRIN
/
GORTEC 2015-02 CisFRad
/
HPV
/
IMRT
/
JAVELIN HN 100 Trial
/
JCOG
/
NPC
/
p16+ LF-OPC
/
Protonentherapie
/
Radiochemotherapie
/
Radiosensitizer
/
Radiotherapie
/
RCT
/
RCTX
/
RTX
/
TOS
